Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer

Clinical trial NCT00312819 · COMPLETED

Trial details

NCT number: NCT00312819
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2006-03-01
Primary completion: 2009-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.